EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[ 18 F]FDG PET/CT in Advanced Mantle Cell Lymphoma

Domenico Albano iD, Nicola Bianchetti, Anna Talin, Francesco Dondi, Alessandro Re, Alessandra Tucci, Francesco Bertagna

Hematological Oncology · 2025

DOI: 10.1002/hon.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2025. Verfasst von Domenico Albano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Department, ASST Spedali Civili Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Tumor Burden. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mantle cell lymphoma (MCL) is an aggressive non‐Hodgkin lymphoma with poor prognosis. The usefulness of fluorine‐18‐fluorodeoxyglucose positron emission tomography/computed tomography (2‐[ 18 F]FDG PET/CT) and its parameters in the evaluation of treatment response and prognosis is not yet clear. The aim of this study was to investigate the prognostic role of tumor burden and tumor dissemination features derived by 2‐[ 18 F]FDG PET/CT in advanced MCL. We retrospectively included 120 patients with advanced MCL who underwent baseline 2‐ 2‐[ 18 F]FDG PET/CT and end‐of‐treatment (eot) PET/CT. The baseline‐PET images were analyzed visually and semi‐quantitatively by measuring the maximum standardized uptake value body weight (SUVbw), lean body mass (SUVlbm), body surface area (SUVbsa), metabolic tumor volume (MTV), total lesion glycolysis (TLG) and dissemination features (Dmax and Dmax‐bsa). EotPET/CT was judged according to the Lugano classification. Progression‐free survival (PFS) and overall survival (OS) were plotted according to the Kaplan–Meier method. At a median follow‐up of 59 months, relapse/progression occurred in 68 patients while death in 38 patients with a median PFS and OS of 27.2 and 57.6 months, respectively. MIPI score, Bulky disease, Ki‐67 index, metabolic response, pretreatment MTV and TLG were significantly associated with PFS at univariate analysis, but only metabolic response, MTV and TLG were confirmed to be independent prognostic factors. Considering OS, only dissemination features were demonstrated to be prognostic features. In conclusions, metabolic response and metabolic tumor burden parameters (MTV and TLG) are strongest predictor of PFS, while dissemination features may have a significant role for predicting OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Mantle-CellPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Tumor BurdenHumansMaleFemaleMiddle AgedAgedPrognosisAdultRetrospective StudiesAged, 80 and overRadiopharmaceuticals

Stichwörter der Autor:innen

18F‐FDG PET/CTDmaxMTVMantle cell lymphomadisseminationprognosis

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Nuclear Medicine Department, ASST Spedali Civili Brescia, Brescia, Italy.
  • Università degli Studi di Brescia, Brescia, Italy.
  • Division of Hematology, ASST Spedali Civili, Brescia, Italy.

ORCID-Profile: Domenico Albano

Zitieren

APA

Albano, D., Bianchetti, N., Talin, A., Dondi, F., Re, A., Tucci, A., & Bertagna, F. (2025). Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[ 18 F]FDG PET/CT in Advanced Mantle Cell Lymphoma. Hematological Oncology. https://doi.org/10.1002/hon.70009

Vancouver

Albano D, Bianchetti N, Talin A, Dondi F, Re A, Tucci A, et al. Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[ 18 F]FDG PET/CT in Advanced Mantle Cell Lymphoma. Hematological Oncology. 2025. doi:10.1002/hon.70009

BibTeX
@article{Albano2025,
  author = {Albano, Domenico and Bianchetti, Nicola and Talin, Anna and Dondi, Francesco and Re, Alessandro and Tucci, Alessandra and Bertagna, Francesco},
  title = {Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[ 18 F]FDG PET/CT in Advanced Mantle Cell Lymphoma},
  journal = {Hematological Oncology},
  year = {2025},
  doi = {10.1002/hon.70009}
}
Kostenlos starten →